Theodoros Kelesidis

Professor in the Department of Internal Medicine · UT Southwestern Medical Center

Credentials: · · · ·

History

Adiponectin and cancer: a systematic review
Systematic review or meta-analysis · British Journal of Cancer · 2006 · 380 citations
The emerging problem of linezolid-resistant Staphylococcus
Review · Journal of Antimicrobial Chemotherapy · 2013 · 254 citations
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders
Therapeutic Advances in Gastroenterology · 2012 · First of 2 authors · 241 citations

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $451K · Ut Southwestern Medical Center
2023–2026
Targeting Early Instigators of Vascular Inflammation to Prevent and/or Delay Vascular Aging in Chronic Treated HIV
National Institute on Aging · R01
Contact PI · $2M · Ut Southwestern Medical Center
2018–2025
In vivo Modelling of Therapeutic Strategies for Prevention of HIV-Related Fibrosis and Fatty Liver Disease in Chronic Treated HIV-1 Infection
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $429K · University of California Los Angeles
2018–2022
Elucidating the Impact of Molecular Signatures of Immune Senescence on Aging in Chronic Treated HIV
National Institute on Aging · R03
Contact PI · $156K · University of California Los Angeles
2018–2021

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Principal investigator · Completed · Early phase 1
University of Texas Southwestern Medical Center
2024–2025
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
2024–2026
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
Principal investigator · Completed · Phase 1, Phase 2
University of California, Los Angeles
2022–2023
Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)
Principal investigator · Completed · Phase 1, Phase 2
University of California, Los Angeles
2019–2021